PULSE BIOSCIENCES INC
NASDAQ: PLSE (Pulse Biosciences, Inc)
Last update: 6 hours ago17.37
0.45 (2.66%)
| Previous Close | 16.92 |
| Open | 16.86 |
| Volume | 118,458 |
| Avg. Volume (3M) | 162,222 |
| Market Cap | 1,068,545,152 |
| Price / Sales | 60.23 |
| Price / Book | 13.18 |
| 52 Weeks Range | |
| Earnings Date | 27 Mar 2025 |
| Diluted EPS (TTM) | -0.830 |
| Total Debt/Equity (MRQ) | 10.57% |
| Current Ratio (MRQ) | 11.93 |
| Operating Cash Flow (TTM) | -33.98 M |
| Levered Free Cash Flow (TTM) | -18.81 M |
| Return on Assets (TTM) | -38.15% |
| Return on Equity (TTM) | -70.28% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Pulse Biosciences, Inc | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.50 |
|
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 80.81% |
| % Held by Institutions | 9.88% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Griffin Asset Management, Inc. | 31 Dec 2024 | 237,547 |
| Westside Investment Management, Inc. | 31 Dec 2024 | 55,121 |
| Panoramic Capital, Llc | 31 Dec 2024 | 48,571 |
| Spotlight Asset Group, Inc. | 30 Jun 2024 | 40,290 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |